AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23683751 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod cream (once daily, five times a week for 6 weeks)
Number of subjects: 601
Study 23683751 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil cream (twice daily for 4 weeks)
Number of subjects: 601
Study 23683751 — intervention group
Group type: COMPARATOR
Intervention: Imiquimod vs MAL-PDT
Number of subjects: 601
Study 23683751 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil vs MAL-PDT
Number of subjects: 601
Study 23683751 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil vs Imiquimod
Number of subjects: 601
Study 19957035 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 780
Study 18727125 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (angioplasty)
Number of subjects: 0
Study 18727125 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study 16083385 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean MMPI-2 F, Fb, F-K, and F(p) scales
Number of subjects: 0
Study 16083385 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean MMPI-2 L, K, and S scales
Number of subjects: 0
Study 12161831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic tilt exercise
Number of subjects: 14
Study 12161831 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal hollowing exercise
Number of subjects: 14
Study 12161831 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stability test (TST) exercise
Number of subjects: 14
Study 10382464 — intervention group
Group type: EXPERIMENTAL
Intervention: Home apnea monitors (used by 52 parents)
Number of subjects: 104
Study 10382464 — intervention group
Group type: COMPARATOR
Intervention: Non-monitored group (52 parents)
Number of subjects: 104
Study 7675553 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage (PD)
Number of subjects: 16
Study 7675553 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure physiotherapy (PEP)
Number of subjects: 16
Study 7675553 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest compression physiotherapy (HFCC)
Number of subjects: 16
Study 7675553 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (CONT)
Number of subjects: 16
Study 1974429 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutoprazepam 4 mg
Number of subjects: 18
Study 1974429 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutoprazepam 2 mg
Number of subjects: 18
Study 1974429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 7323625 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiapride (300 mg/day orally for 30 days)
Number of subjects: 50
Study 31865235 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Exposure treatment condition (at least 15 activities, exposed once)
Number of subjects: 8
Study 31865235 — intervention group
Group type: COMPARATOR
Intervention: Repeated Exposure treatment condition (3 activities, exposed during five sessions each)
Number of subjects: 8
Study 31865235 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Exposure treatment condition
Number of subjects: 8
Study 30182286 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (SB)
Number of subjects: 71
Study 30182286 — intervention group
Group type: EXPERIMENTAL
Intervention: BA + SB (BASB)
Number of subjects: 71
Study 30182286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 71
Study 30182286 — intervention group
Group type: COMPARATOR
Intervention: BA
Number of subjects: 71
Study 30182286 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 71
Study 28703931 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 66
Study 28703931 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 66
Study 25592159 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide Risk Management Protocol (SRMP)
Number of subjects: 302
Study 24337659 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (4-7 vol%)
Number of subjects: 40
Study 24337659 — intervention group
Group type: COMPARATOR
Intervention: Propofol (2-3.5 μg/ml)
Number of subjects: 40
Study 23174584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 180
Study 23174584 — intervention group
Group type: COMPARATOR
Intervention: Regular dose atorvastatin
Number of subjects: 180
Study 19999921 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track group (epidural analgesia, early ambulation, oral feeding)
Number of subjects: 100
Study 19999921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no epidural analgesia, early ambulation, early oral diet)
Number of subjects: 100
Study 19999921 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track group
Number of subjects: 100
Study 19999921 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 16889491 — intervention group
Group type: EXPERIMENTAL
Intervention: T(4) treatment in DS infants (N = 99)
Number of subjects: 196
Study 16889491 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment in DS infants (N = 97)
Number of subjects: 196
Study 12963912 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 19
Study 12963912 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 19
Study 10378525 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 382
Study 10378525 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 382
Study 10378525 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser cautery
Number of subjects: 382
Study 10378525 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal resection without lateral displacement
Number of subjects: 382
Study 10378525 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal resection with lateral displacement
Number of subjects: 382
Study 10378525 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbinectomy
Number of subjects: 382
Study 8721797 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind assessments by 7 raters
Number of subjects: 36
Study 8721797 — intervention group
Group type: COMPARATOR
Intervention: Open assessments by 7 raters
Number of subjects: 36
Study 1818603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dequalinium chloride
Number of subjects: 6
Study 1818603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanguinarine
Number of subjects: 6
Study 1818603 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 6
Study 6668603 — intervention group
Group type: EXPERIMENTAL
Intervention: Fifteen session psychosocial smoking prevention strategy
Number of subjects: 902
Study 6668603 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster sessions conducted during the year after completion of the program
Number of subjects: 902
Study 30341035 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Efficiency Hemodialysis (HEHD)
Number of subjects: 10
Study 30341035 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdilution Hemodiafiltration (HDFpost)
Number of subjects: 10
Study 30341035 — intervention group
Group type: EXPERIMENTAL
Intervention: Predilution Hemodiafiltration (HDFpre)
Number of subjects: 10
Study 30341035 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 10
Study 30341035 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Efficiency Hemodialysis (HEHD), Postdilution Hemodiafiltration (HDFpost), Predilution Hemodiafiltration (HDFpre)
Number of subjects: 10
Study 29775087 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 0
Study 29775087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26462702 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR alone
Number of subjects: 246
Study 26462702 — intervention group
Group type: EXPERIMENTAL
Intervention: SC alone
Number of subjects: 246
Study 26462702 — intervention group
Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 246
Study 26462702 — intervention group
Group type: EXPERIMENTAL
Intervention: SC + ILR
Number of subjects: 246
Study 24075141 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten- and casein-free diet
Number of subjects: 0
Study 23132262 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia and TAP block (Group T)
Number of subjects: 68
Study 23132262 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone (Group G)
Number of subjects: 68
Study 21111365 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase (up to 2 mg) administered intraluminally, with a second dose if indicated and a third placebo dose.
Number of subjects: 97
Study 21111365 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by up to two doses of tenecteplase if needed.
Number of subjects: 97
Study 18078506 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee arthroscopy and an 8‐week home exercise program
Number of subjects: 56
Study 18078506 — intervention group
Group type: COMPARATOR
Intervention: 8‐week home exercise program only (Control)
Number of subjects: 56
Study 15675979 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids (500 ml intravenously during 4 h)
Number of subjects: 34
Study 15675979 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution (500 ml intravenously during 4 h)
Number of subjects: 34
Study 12166794 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple dye once followed by daily alcohol application
Number of subjects: 634
Study 12166794 — intervention group
Group type: COMPARATOR
Intervention: Daily alcohol application alone
Number of subjects: 634
Study 10214005 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia (34.5 degrees C)
Number of subjects: 173
Study 10214005 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (36.0 degrees C)
Number of subjects: 173
Study 7885622 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet high in monounsaturated fat and low in carbohydrate
Number of subjects: 0
Study 2281848 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.2-0.3 mg/kg b.w. i.v., group I n = 10)
Number of subjects: 30
Study 2281848 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.3-0.4 mg/kg b.w., i.v., group II n = 10)
Number of subjects: 30
Study 2281848 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (0.03-0.04 mg/kg b.w., i.v., group III n = 10)
Number of subjects: 30
Study 484256 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 20
Study 484256 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 20
Study 484256 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated hyperthyroid)
Number of subjects: 20
Study 30987765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lung sliding sign
Number of subjects: 74
Study 30987765 — intervention group
Group type: COMPARATOR
Intervention: Auscultation
Number of subjects: 74
Study 27494272 — intervention group
Group type: EXPERIMENTAL
Intervention: Tip cryotherapy
Number of subjects: 101
Study 27494272 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 101
Study 26672085 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 452
Study 26672085 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan
Number of subjects: 452
Study 23890856 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (total omega-3 6 g/d)
Number of subjects: 78
Study 23890856 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study 23890856 — intervention group
Group type: COMPARATOR
Intervention: Crossover group (21 fish oil patients who crossed over to control)
Number of subjects: 78
Study 21532464 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 213
Study 21532464 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 213
Study 19246952 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral intake of 300 mg alpha‐tocopheryl‐acetate for 2 months
Number of subjects: 39
Study 19246952 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 39
Study 16987583 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic (Welch Allyn‐MRL PIC; 70, 100, 150, 200 and 300J)
Number of subjects: 139
Study 16987583 — intervention group
Group type: COMPARATOR
Intervention: Monophasic (Hewlett Packard Codemaster XL; 100, 200, 300, 360 and 360J)
Number of subjects: 139
Study 14529975 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin A for chemoprevention of second primary tumors
Number of subjects: 569
Study 14529975 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection for SPLC
Number of subjects: 569
Study 14529975 — intervention group
Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 569
Study 14529975 — intervention group
Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 569
Study 10753003 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction therapy combined with sleep hygiene
Number of subjects: 39
Study 10753003 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap modification of sleep restriction therapy combined with sleep hygiene
Number of subjects: 39
Study 10753003 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene alone
Number of subjects: 39
Study 8631189 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (naringin, 887 mg/ml)
Number of subjects: 13
Study 8631189 — intervention group
Group type: COMPARATOR
Intervention: Herbal tea
Number of subjects: 13
Study 1420493 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine premixed dialysis solution
Number of subjects: 12
Study 1420493 — intervention group
Group type: COMPARATOR
Intervention: Control dialysis solution
Number of subjects: 12
Study 6703415 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide nasal spray
Number of subjects: 60
Study 6703415 — intervention group
Group type: COMPARATOR
Intervention: Flunisolide nasal spray
Number of subjects: 60
Study 31451013 — intervention group
Group type: EXPERIMENTAL
Intervention: everolimus-eluting drug-eluting stents (DES)
Number of subjects: 1498
Study 31451013 — intervention group
Group type: COMPARATOR
Intervention: bare-metal stents (BMS)
Number of subjects: 1498
Study 28467737 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week resistance training programme
Number of subjects: 16
Study 28467737 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 27455961 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 354
Study 27455961 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 354
Study 24585000 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum oxytocin infusion of 80 U/500 mL over 1 hour
Number of subjects: 1329
Study 24585000 — intervention group
Group type: COMPARATOR
Intervention: Postpartum oxytocin infusion of 80 U/500 mL over 8 hours
Number of subjects: 1329
Study 22798287 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity programme (experimental group)
Number of subjects: 70
Study 20673141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at ST 36
Number of subjects: 15
Study 20673141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at ST 36 plus PC 6
Number of subjects: 15
Study 20673141 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at PC 6
Number of subjects: 15
Study 20673141 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 15
Study 17331928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (US)
Number of subjects: 188
Study 17331928 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ultrasound and nerve stimulation (USNS)
Number of subjects: 188
Study 17331928 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulation (NS)
Number of subjects: 188
Study 16375199 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled short-acting beta2 agonist
Number of subjects: 0
Study 16375199 — intervention group
Group type: COMPARATOR
Intervention: Routine spirometric reversibility testing
Number of subjects: 0
Study 12226605 — intervention group
Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 9
Study 12226605 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumice-laser (pumiced for 3 seconds and treated with a 325 mW, 5-mm diameter laser beam for 60 seconds)
Number of subjects: 9
Study 12226605 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumice-etch-laser (pumiced for 3 seconds, acid-etched with 30% phosphoric acid for 30 seconds, and treated for 60 seconds with laser)
Number of subjects: 9
Study 12226605 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser only (treated for 60 seconds with laser)
Number of subjects: 9
Study 11150453 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive equation using birth weight and 5-minute Apgar scores
Number of subjects: 1054
Study 11150453 — intervention group
Group type: EXPERIMENTAL
Intervention: High, intermediate, and low risk stratification based on birth weight and Apgar scores
Number of subjects: 1054
Study 9839347 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 7951277 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (with side effects)
Number of subjects: 0
Study 7951277 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (without side effects)
Number of subjects: 0
Study 7951277 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment noncompliers
Number of subjects: 0
Study 7951277 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical scenario with treatment compliance equal to placebo compliance
Number of subjects: 0
Study 3282478 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 526
Study 3282478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study 29273873 — intervention group
Group type: EXPERIMENTAL
Intervention: Video review group
Number of subjects: 16
Study 29273873 — intervention group
Group type: COMPARATOR
Intervention: No video review group
Number of subjects: 16
Study 27085769 — intervention group
Group type: EXPERIMENTAL
Intervention: fasted-state HIIE (HIIEfast)
Number of subjects: 10
Study 27085769 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE
Number of subjects: 10
Study 27085769 — intervention group
Group type: EXPERIMENTAL
Intervention: fasted-state exercise
Number of subjects: 10
Study 27085769 — intervention group
Group type: COMPARATOR
Intervention: MICE
Number of subjects: 10
Study 27085769 — intervention group
Group type: COMPARATOR
Intervention: no exercise (control)
Number of subjects: 10
Study 25614598 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (T)
Number of subjects: 60
Study 25614598 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and increased caloric intake (T-iD)
Number of subjects: 60
Study 25614598 — intervention group
Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 60
Study 25614598 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 60
Study 23510037 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg ranibizumab, treated as needed every 4 weeks (cohort A)
Number of subjects: 88
Study 23510037 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg ranibizumab, treated as needed every 6 weeks (cohort B)
Number of subjects: 88
Study 21279645 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat flour inhalation
Number of subjects: 25
Study 21279645 — intervention group
Group type: EXPERIMENTAL
Intervention: Rye flour inhalation
Number of subjects: 25
Study 21279645 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 25
Study 17620665 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouragement by family and/or friends (social network characteristic)
Number of subjects: 1475
Study 17620665 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective norms (social network characteristic)
Number of subjects: 1475
Study 17620665 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception that screening was normative (social network characteristic)
Number of subjects: 1475
Study 16303790 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BI)
Number of subjects: 0
Study 16303790 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (MI)
Number of subjects: 0
Study 12749482 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets (ITNs)
Number of subjects: 1722
Study 12749482 — intervention group
Group type: COMPARATOR
Intervention: Control (no ITNs)
Number of subjects: 1722
Study 12749482 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets (ITNs) re-treated every six months
Number of subjects: 1722
Study 10947754 — intervention group
Group type: COMPARATOR
Intervention: Flexiblade laryngoscope with lever in neutral position
Number of subjects: 200
Study 10947754 — intervention group
Group type: COMPARATOR
Intervention: Flexiblade laryngoscope with lever depressed
Number of subjects: 200
Study 10947754 — intervention group
Group type: COMPARATOR
Intervention: Flexiblade laryngoscope
Number of subjects: 200
Study 8638833 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 63
Study 8638833 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 63
Study 1593216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg two times a day) with dimethyl sulfoxide (500 mg four times daily)
Number of subjects: 169
Study 1593216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg two times a day) with allopurinol (50 mg four times a day)
Number of subjects: 169
Study 1593216 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (400 mg two times a day)
Number of subjects: 169
Study 1593216 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (400 mg at bedtime)
Number of subjects: 169
Study 1593216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg two times a day) with dimethyl sulfoxide or allopurinol
Number of subjects: 169
Study 29193877 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment for 10 days
Number of subjects: 80